Correlation between phenotypic and genotypic drug resistance to kanamycin and amikacin in clinical isolates of .
作者信息
Ahmadi Azam, Sadrnia Maryam, Arjomandzadegan Mohammad, Titov Leonid
机构信息
Infectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran.
Department of Biology, Payame Noor University, Tehran, Iran.
出版信息
Iran J Microbiol. 2020 Oct;12(5):503-504. doi: 10.18502/ijm.v12i5.4613.
Abstract
摘要
相似文献
1
Correlation between phenotypic and genotypic drug resistance to kanamycin and amikacin in clinical isolates of .
Iran J Microbiol. 2020 Oct;12(5):503-504. doi: 10.18502/ijm.v12i5.4613.
2
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Int J Mycobacteriol. 2016 Mar;5(1):1-6. doi: 10.1016/j.ijmyco.2015.09.001. Epub 2015 Oct 1.
3
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01299-16. Print 2017 Feb.
4
Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
J Antimicrob Chemother. 2011 Jun;66(6):1247-54. doi: 10.1093/jac/dkr109. Epub 2011 Mar 21.
5
Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
Diagn Microbiol Infect Dis. 2013 Oct;77(2):138-42. doi: 10.1016/j.diagmicrobio.2013.06.031. Epub 2013 Aug 12.
6
Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Ann Lab Med. 2018 Jul;38(4):316-323. doi: 10.3343/alm.2018.38.4.316.
7
Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2005 Aug;49(8):3192-7. doi: 10.1128/AAC.49.8.3192-3197.2005.
8
Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 1998 May;42(5):1295-7. doi: 10.1128/AAC.42.5.1295.
9
Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
Indian J Exp Biol. 2009 Jun;47(6):520-2.
10
Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China.
J Antimicrob Chemother. 2013 Jul;68(7):1537-42. doi: 10.1093/jac/dkt082. Epub 2013 Mar 28.
本文引用的文献
1
Novel Mutations in Gene of Pyrazinamide Resistant Clinical Isolates of .
Sci Pharm. 2018 Apr 16;86(2):15. doi: 10.3390/scipharm86020015.
2
Factors associated with tuberculosis treatment outcomes among tuberculosis patients attending tuberculosis treatment centres in 2016-2017 in Mogadishu, Somalia.
Pan Afr Med J. 2017 Nov 2;28:197. doi: 10.11604/pamj.2017.28.197.13439. eCollection 2017.
3
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.
J Clin Microbiol. 2014 Mar;52(3):781-9. doi: 10.1128/JCM.02701-13. Epub 2013 Dec 18.
4
Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance.
Clin Infect Dis. 2011 Jun;52(11):1350-5. doi: 10.1093/cid/cir146.
5
Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.
J Clin Microbiol. 2011 Apr;49(4):1588-90. doi: 10.1128/JCM.00113-11. Epub 2011 Feb 2.
6
Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.
J Clin Microbiol. 2010 Aug;48(8):2749-53. doi: 10.1128/JCM.00652-10. Epub 2010 Jun 16.
7
Investigation of environmental and host-related risk factors for tuberculosis in Africa. II. Investigation of host genetic factors.
Am J Epidemiol. 2002 Jun 1;155(11):1074-9. doi: 10.1093/aje/155.11.1074.
8
Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene.
J Clin Microbiol. 1998 May;36(5):1220-5. doi: 10.1128/JCM.36.5.1220-1225.1998.
Zotero 插件